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CASE REPORT
IntroductIon
Liver cirrhosis is a diffuse process character-
ized by fibrosis and the conversion of normal liver 
architecture into structurally abnormal nodul. 
At the cirrhotic stage, liver disease is considered 
irreversible.1 The number of patients with cirrhosis 
who require surgery is increasing. Despite advances in 
antiviral therapeutics, cirrhosis secondary to hepatitis 
B, C and chronic alcohol abuse continues to grow 
in number. At the same time, medications and 
treatments aim at improving survival in these patients 
have been increasing. Therefore, it can be expected 
that a growing number of patients with cirrhosis 
will undergo surgery. An estimated 1 in 700 patients 
admitted for elective surgery has abnormal liver 
enzyme levels. Some have estimated that as many 
as 10% of patients with advanced liver disease will 
undergo surgery in the last 2 years of their lives.2
Patients with liver cirrhosis are at particularly 
high risk for morbidity and mortality due to stress of 
surgery and effects of general anesthesia. Patients with 
cirrhosis is not contraindication for surgery. Certain 
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types of surgery can be undertaken safely if patients 
are evaluated and managed carefully. Child class C 
cirrhosis is a relatively contraindicated to elective 
surgery, as such patients are likely to develop 
postoperative complications and mortalities.3
We report a case of patient with advanced liver cir-
rhosis who would undergo abdominal surgery. Some 
things need to be considered such as (1) What are 
the effects of liver disease on anesthesia and surgery? 
(2) How is the risk of surgery in cirrhosis patients 
?, (3) How to make perioperative risk assessment, 
evaluation and management of the patients with liver 
cirrhosis?
cASE
A 68 years old male was  admitted  to hospital 
with chief complaint of dyspneu. He did not have past 
history of upper and lower gastrointestinal bleeding. 
According to physical examination,  he was apparently 
pale, fully alert, and the vital signs were still normal. 
The conjunctivae was pale and sclera was jaundice. The 
jugular venous pressure was normal. Heart and lung 
were also normal. Ascites and left hernia inguinalis 
were detected on abdominal examination. Both his 
legs were swollen. His nutritional state was moderate 
malnutrition. 
The laboratory examination showed that 
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hemoglobin level was 10.7 g/dL, leukocyte count 
was 12,500/mm3, the platelet count was decreased 
64,000/mm3, creatinine 0.9 mg/dL, ureum level was 
32 mg/dL, transaminase level was slightly increased 
(ALT= 85 mg/dL dan AST = 40 mg/dL), bilirubin was 
increased (total = 7.28 mg/dL, direct 5.60 mg/dL), 
protein level 6.8 mg/dL, albumin = 2.5 mg/dL, 
globulin = 4.3 mg/dL, electrolyte level was still normal 
(natrium = 135 mmol/L, potassium 4.0 mmol/L and 
chloride 112 mmol/L), fasting blood sugar 81 mg/
dL dan post prandial was 112 mg/dL and the  pro-
thrombin time was increased (44 second, normal = 
26-40 second), hepatitis seromarker Anti HCV was 
negative but  HbsAg was positive.  
The electrocardiography (ECG) and chest X-ray 
were unremarkable. Ultrasonography suggested liver 
cirrhosis with ascites without splenomegali. According 
the Child-Pugh class, his score was 11 (Child-Pugh 
class C). The diagnosis for this patient was advanced 
liver cirrhosis due to hepatitis B virus infection and 
left hernia inguinalis. Patient were treated by nutrition 
support, diuretics (furosemide and spironolactone), 
intravenous vitamin K and hepatoprotector. 
On 21st day of hospitalization, the patient told 
the doctor that he felt a terrible pain in the in-
guinal area. His hernia was strangulated. Then 
the consultant surgeon decided to undergo emergent 
abdominal surgery. Before surgery, hypoalbuminemia, 
coagulation status and ascites were corrected. 
He received 20% albumin transfusion 100 mL/day for 
2 days, and platelet transfusion. Fifteen packs of plate-
let transfusion were transfused and the platelet level 
increased from 64,000/mm3 to 148,000/mm3. One 
day before surgery, the anaesthesiologis assessed 
the patient condition. The anaesthesiologist’s 
assessment showed that the patient had high risk 
catagory with 3rd grade ASA.
On the 23nd day of hospitalization, patient 
underwent emergency abdominal surgery with regional 
anesthesia. The surgery procedure consumed one hour. 
On the 13th day post surgery, the site of operation was 
bleeding and the wound was open. The laboratory 
results revealed platelet 80,000/mm3, and PT was 
increased 5 seconds  above the control. Platelet 
transfusion was given and intravenous vitamin K were 
administered. Because his general condition gradually 
increased better, he was permited to discharge from 
hospital. But, on the 12nd day after discharged from 
hospital (52nd day of care), he was re-admitted in 
hospital with coma hepaticum. Before 24 hours of 
hospitalization, he died due to hepatic encephalopathy 
and hepatorenal syndrome (ureum levels 167 mg/dL 
and creatinine 2.1 mg/dL).
 
dIScuSSIon
We reported a case of an elderly male patient with 
advanced liver cirrhosis (Child-Pugh class C) who 
had to undergo emergent abdominal surgery because 
his hernia inguinalis was trapped. About 2 weeks 
after surgery he died because of encephalopaty and 
hepatorenal syndrome. Actually, he was at very high 
risk to develop complications and mortality during 
and after surgery. 
Patients with cirrhosis are at particularly high risk 
for morbidity and mortality due to both  the stress of 
surgery and the effects of general anesthesia. The risk 
for morbidity and mortality are influenced by  the 
type of surgery and the extent of liver dysfunction.4 
The risk appears to be much higher with open 
abdominal surgery than with laparoscopic surgery, 
to be much higher in abdominal and cardiac surgery 
than non abdominal and cardiac surgery. There were 
reports showed that the  mortality rate in patients with 
liver cirrhosis were 20-50% for various type open 
abdominal surgery.5 Mansour et al, reported that 
the mortality rate in patients with cirrhosis after 
emergent abdominal surgery was 50%, compare 18% 
for elective surgery (p = 0.001).6 
The more extent of liver dysfunction the more 
higher mortality rate risk. Garrison reported, liver cir-
rhosis patients who underwent surgery with prothrom-
bin time was greater than that of control. Fourty seven 
percent of all patients died compared to only 7% when 
prothrombin time was less than or equal to conrol 
value. Patients who underwent emergency procedure 
57% died compare to only 10% who did not undergo 
emergency surgery. Still in the same study, mortality 
rate in cirrhosis patients with Child classification A was 
10%, Class B was  31% and Class C was 76%.2
There is no specific tool to estimate the extent of 
liver dysfunction. Conventional biochemical markers 
of hepatobiliary disease correlate poorly with degree of 
hepatic dysfunction because of the lack of individual 
specificity.7 The  most commonly used approach for 
prediction of perioperative risk is based on the sys-
tem developed by Child and Turcotte. Child’s class 
is acurate preoperative  predictive factor in cirrhosis 
patients. Now, the Child-Pugh score is used to predict 
perioperative morbidity and mortality rates for patients 
undergoing intra-abdominal surgery. It corporates 
a  combinat ion of  3  biochemical  e lements 
(i.e. prothrombin time, albumin dan bilirubin level), 
and 3 clinical features (i.e. nutritional state, presence of 
ascites and encephalopathy) to assess primary 
functions of the liver.2,4,8 
Liver have has multiple function, as site of pro-
tein synthesis, metabolism of nutrients and drugs, 
excretion and detoxification of endogenous toxins and 
exogenous agent. Liver damage in cirrhosis patients 
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may cause several hemodinamic, hematological, 
metabolic and other abnormalities .  Several 
pathophysiological factors contribute to increased 
perioperative mortality in patients with liver diasese. 
A hyperdynamic state with increased cardiac output, 
decreased systemic vasculare resistance and increased 
intravascular volume is typical in cirrhosis. Renal 
blood flow tends to decrease, and renal failure may 
develop in patients with portal hypertension and ascites 
( the hepatorenal syndrome).  Local hepatic 
autoregulation of arterial blood flow is impaired, 
making cirrhosis liver lesstolerant of hemodynamic 
changes. These alterations render the cirrhotic 
liver more vulnarable to hemorrhage, hypovolemia, 
hypotension and hypoxemia.9 
Several studies have shown that both regional and 
general anesthetic procedure may decrease hepatic 
blood flow as a result of systemic vasodilatation and 
slighly negative inotropic effect.7,10 Stress due to 
surgery, with concomitant catecholamine release and 
neurohormone responses, may also induce changes in 
liver hemodinamycs that lead to hepatic dysfunction. 
The greater the degree of hemorrhage with surgery, 
the greater the fall in hepatic blod flow and change of 
ischemic injury to the liver.7,11
Liver diasease is associated with a wide range 
of abnormalities of coagulation system. Thrombo- 
cytopenia, coagulation factor abnormalities and 
disseminated inravascular coagulation (DIC) maybe 
induced severe bleeding. These are the factors that 
contribute to defective hemostasis in patients with 
liver disease: decreased synthesis of procoagulant 
anticoagulant proteins, impaired clearence of acti-
vated coagulation factors, nutritional deficiency e.g. 
vitamin K, folate, splenomegali (portal hypertension), 
qualitative platelet defects and bone marrow supression 
of thrombopoiesis.12
As the liver is a major site of drug metabolism, 
alterations in hepatic function may result in a prolonged 
duration of action of agents that are predominantly 
metabolized by this organ. Drugs such as sedatives 
or narcotic analgetics that affect the central nervous 
system may precipitate hepatic encephalopathy. 
In patient with liver cirrhosis the drug clearence maybe 
decreased. The metabolism of the benzodiazepine 
sedative and regional anesthetic agents can be 
prolonged.1
All synthetic functions of the liver are depressed 
in cirrhosis. Hypoalbuminemia is common and wound 
healing is delayed. Glucosa utilization is impaired 
and increased plasma levels of growth hormone  and 
glucagon induce glucosa intolerance. Decreased 
elimination of ammonia and other neurotoxin may 
cause encephalopathy. The hypoglobuminema is as-
sociated with an impaired immune defense system and 
elevated risk of post-operative infections.9 
It has been shown that converting Child C patient 
to Child B preoperatively improved survival after 
surgery.13 Hence, proper perioperative evaluation and 
management which addressed the common features 
of advanced liver disease may decrease the risk of 
complications or death following surgery. Before 
surgery, particularly attention should be paid to the 
management of coagulation status, renal function, 
fluid and electrolite, malnutrition, encephalopaty and 
ascites.7,8,14,15
Coagulopathy and trombocytopenia should be 
corrected with replenishment of vitamin K, 
administration of fresh-frozen plasma (FFP), and 
possibly cryoprecipitate transfusion are recommended 
to reduce a prothrombin time within 3 seconds of 
normal time and to achieve a goal of platelet counts 
of  > 50,000/mm3. 
The presence of ascites may influence respiratory 
mechanics and risk of abdominal wound dehiscence. 
In general, ascites should be treated aggressively 
with diuretic and or large-volume paracentesis with 
albumin if necessary before surgery. Infection, 
diuretics, metabolic alkalosis, constipation, use CNS 
depressants, hypoxia, sepsis, azotemia, or gastro- 
intestinal bleeding in the pre/postoperative periods may 
induced encephalopathy. Correction of electrolite 
abnormalities, treatment of infection, branched chain 
amino acid therapy, and gastrointestinal bleeding, and 
restriction of sedatives help prevent encephalopathy. 
Malnutrition is comon in patiens with cirrhosis. Enteral 
or parenteral  nutrition may be helpful in improving 
the patient’s Child class dan in reducing mortality in 
those with cirrhosis and malnutrition.
Prevention of renal dysfunction, careful attention 
to volume status, and to avoid nephrotoxic agents 
are critical point to prevent hepatorenalsyndrome. 
In patients with cirrhosis, liver failure is the most 
common cause of post-operative mortality. 
Hepatocellular injury is most commonly due to 
the effects of anesthesia, intraoperative hypotension, 
sepsis, or viral hepatitis. So, in he post-operative 
period, the patients must be observed closely for 
sign of acute hepatic decompensation, such as 
worsening jaundice, encephalopathy, and ascites. 
The prothrombine time and serum bilirubin level are 
probably the best measures of hepatic function. Re-
nal function should be monitored as well because of 
the risk of hepatorenal syndrome. Serum glucose 
levels should be followed closely, because 
hypoglycemia often accompanies post operative liver 
falure.
In this case, patient died caused by encephalopathy 
and hepatorenal syndrome. The problem was not only 
the patient was at high risk of mortality rate, but also 
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post-operative monitoring had not been done optimally. 
Patients was permitted to discharge from hospital 
because his condition was apparently good. 
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